Launching the AWiSE Seminar Series

  • January 16 08:01pm
  • Written by: Samantha Le
  • Categories:News

“Founders Keepers”

Tuesday, January 29th, 3:30-5:30 PM at CNSI Auditorium

 

IMG_8985

The Advancing Women in Science and Engineering (AWiSE) program will host its first seminar January 29th, entitled “Founders Keepers.” Three female company founders and CEOs will discuss their experiences in launching successful biotech businesses.

We invite you to listen to a discussion on how our speakers rose to key leadership positions, overcame challenges, and are now shaping the industries in which they are involved. Please join us for this valuable seminar on innovative strategies for success and sources of inspiration from some incredible female leaders in the fields of science and bioengineering.

Moderator:

Betsy Knapp Founder & CEO, BigPictures Investors LLC; Board Member of the UCLA Foundation

Betsy has extensive management experience in creating strategic direction for business growth. She is an entrepreneur who has been investing and supporting early stage growth companies for 39 years. She serves as a repeat guest lecturer in the MBA program of Anderson Graduate School of Management at UCLA and founded the Entrepreneur’s Hall of Anderson Graduate School of Management at UCLA.

Panel Speakers:

Jennifer Neff Founder & CEO, Allvivo Vascular, Inc.

Jennifer is an accomplished scientist, inventor, and entrepreneur. Dr. Neff drove her research discoveries toward commercialization and has successfully raised several rounds of funding. Jennifer has held the position of Chief Technology Officer until recently, when she was named CEO of the company.

France Helfer President, CEO & Board, Halo Healthcare, Inc.

France brings 30 years of experience and has been entrepreneur, investor, executive, and leader. She also serves on several boards and acts as advisor. France has mentored venture teams to winning business plan competitions and serves on several leadership initiatives to advance women in science.

Stephanie Hsieh CEO, Meditope Biosciences, Inc.

Stephanie earned a BA in Biochemistry and Mathematics from Wellesley, a JD from Columbia, and an MBA from Stanford. She brings together tremendous enthusiasm and knowledge to the life science industry, where she has succeeded in many roles, including entrepreneur, intellectual property director, and CEO.

 

 

Register Here

 

 

AWiSE_logo

AWISE Event Flyer

Directions to CNSI

New Bioengineering Course

  • December 03 08:12pm
  • Written by: Samantha Le
  • Categories:News

BIOENGR 233A: Advancing Bioengineering Innovations I – Unmet Needs

The UCLA Business of Science Center is pleased to announce the launch of a new course for graduate and professional students to proactively contribute in the design and creation of cutting edge medical device technology.

  • 8 Unit Course (4 units per Quarter)
  • Winter and Spring Quarter commitment desired
  • No course prerequisites required
  • Available to all UCLA Graduate and Professional Students
  • Requires faculty permission

 

Description: The Advancing Bioengineering Innovations (ABI) program is a two-quarter long course designed to teach students about the medical device design process through lectures, guest speakers, and a hands-on project. Multi-disciplinary teams of graduate students will evaluate actual unmet medical needs identified in the UCLA Hospital System and invent and develop practical solutions that address these needs over the Winter.  The team-based project component of the course will be complemented by lectures and panels from UCLA faculty and industry experts to provide additional teaching and guidance on the product development process and entrepreneurship as it relates to medical devices.

The goals of the ABI program are to develop medical device solutions that improve patient care and prepare students for careers in healthcare, product development, and entrepreneurship.  The Winter and Spring series is open to students enrolled in all graduate programs across campus (medicine, management, engineering, life sciences, law, dentistry, design, etc.) although final course enrollment is at the discretion of the faculty.  Students interested in enrollment into the course should register electronically through URSA (if possible) and email the attached Enrollment Survey and a CV to Arnold Suwarnasarn (ASuwarnasarn@mednet.ucla.edu) as soon as possible.

ABI Winter Syllabus

ABI Enrollment Survey

Schedule:  Wednesdays 4:00-6:50 PM

Faculty:  Dr. Kalyanam Shivkumar, Dr. Ben Wu, Roy Doumani

Fellows:  Brittany Berry-PuseyArash SafaeiArnold Suwarnasarn 

Course ID: 650198201
http://www.registrar.ucla.edu/schedule/detselect.aspx?termsel=13W&subareasel=BIOENGR&idxcrs=0233A

3rd Annual Venture Team Competition Call for Proposals

  • November 19 05:11pm
  • Written by: Samantha Le
  • Categories:News

2013 Venture Competition 

The Business of Science Center announces a call for proposals for the 2013 Spring UCLA BSC Venture Competition. We invite the UCLA scientific, engineering, and business communities to submit descriptions of innovative medical technologies to compete for $30,000 proof-of-concept funding.

Venture Teams will assess the commercial feasibility of the technology (potential markets and competitors, intellectual property landscape, and commercial development roadmap) and present their ‘pitch’ for the technology before a panel of judges comprised of investors, industry experts, and UCLA faculty.

Please refer to the full call for proposals document for all information: Venture Competition 2013 Call for Proposals

General Guidelines

Applications are encouraged from a variety of medical disciplines such as, but not limited to, medical devices, diagnostics, and therapeutics. Other topics of interest include innovative lab or related processes and equipment.
Applicants are encouraged to submit innovations that:

·         are novel,
·         are useful and address an identifiable need, and
·         are protected by a provisional patent application or awarded patent.
Projects are anticipated to range from early stage to those that are ready for market.

Eligibility

At least one team member must be a UCLA research community member.  PRIOR TO SUBMISSION, technologies must be protected by provisional patent or patent, filed by the UCLA Office of Intellectual Property (OIP). If an invention has not been disclosed to UCLA OIP, please visit the OIP website (https://oip.ucla.edu/academic-community/report-a-new-invention) to file an invention report or contact Emily Loughran at UCLA OIP (ELoughran@research.ucla.edu).

Application Deadline and Schedule 

15-Nov. 2012   Call For Proposals

7-Dec. 2012     Priority Deadline

14-Dec. 2012   Submission Deadline

Spring 2013     Competition

Submission 

Please carefully read the Venture Competition 2013 Call for Proposals document for a complete list of submission instructions. The priority deadline is 11:59 PM PST December 7th, 2012. Applications received by the priority deadline will have priority access to the first venture teams formed for the competition and longer time for analysis by the teams prior to the competition date. Final applications are due by 11:59 PM PST December 14th, 2012.

 

2012-2013 Weekly Meeting Schedule

  • November 01 07:11pm
  • Written by: Samantha Le
  • Categories:News

Please join us for our weekly Tuesday  meetings in the Biomedical Sciences Research Building (BSRB) Room 154. We often introduce new technologies, intellectual property information, business market analysis, and encourage active involvement from our attendants to ensure a stimulating and worthwhile session for all.

Please note that our meetings will be held in the Anderson School of Management in Room A301 once per month on the following Tuesdays:

November 20
January 15
*February 26 (Room B301)
March 12
April 16
May 21

*Note Room Change to B Level

Sign up here for our newlsetter to receive updates for each week’s meeting agenda. We look forward to seeing you.

-The BSC Team

Kicking off an Entrepreneurial School Year at UCLA

  • September 27 04:09pm
  • Written by: Samantha Le
  • Categories:News

“Innovation in Medical Technology”

Monday October 1st, 3:30-5:00 at CNSI Auditorium 

Join us as Dr. Kodi Azari discusses advancements in composite  tissue  transplantation and  how multidisciplinary collaboration and creativity has advanced healthcare, leading to increased treatment options and better solutions for patients.

Kodi Azari, MD FACS

Kodi Azari

Kodi Azari, MD, FACS is a Hand, Microvascular, and Reconstructive Plastic Surgeon. Dr. Azari received his education and training from the University of Pittsburgh Medical  Center,  Carnegie  Melon University, and UCLA among other institutions. He is board certified in Plastic Surgery and Hand Surgery and was one of the lead surgeons on the first arm and double hand transplant in the United States as well as the first hand transplant operation on the west coast, which was conducted here at UCLA. His clinical areas of interest include all aspects of hand/wrist, microvascular, reconstructive plastic surgery, and peripheral nerve surgery; however, he is most passionate about the complex reconstruction of severely injured (mutilated) hands. He currently serves as the Chief of the Section of Reconstructive Transplantation and Medical Co-Director of Operation Mend. Dr. Azari has authored numerous research articles, book chapters, and presentations and composite tissue transplantation.

 

Schedule for Cross-Campus Innovation Week Oct. 1-3

Last Chance To Register!

  • September 26 05:09pm
  • Written by: Samantha Le
  • Categories:News

Announcing the last few days to register for the BSC Class: Business of Science, MPharm 287. 

Abstract:

Graduate level course that introduces students to the principles of business and entrepreneurship in technology sectors with an emphasis on life sciences. Learn business skills and knowledge required to perform effectively in a commercial environment and understand the power of academic-industry partnerships.

Entrepreneurship, new business ventures,  financing, legal considerations, and entry and exit strategies will be presented and examined through critical discussion.

 

A Few Key Speakers…

David Feinberg    CEO of UCLA Health System

George Ayoub       Co-Founder of  One Lambda

Ahmed Enany      CEO of SoCalBio

Bill Ouchi           Distinguished Professor at UCLA Anderson School of Management

First Fridays Networking Series at OIP

  • September 10 04:09pm
  • Written by: Samantha Le
  • Categories:News

Every first Friday of the month, the Office of Intellectual Property (OIP) will be hosting a morning educational and networking series from 9:00 AM to 10:30 AM. Short instructional presentations will be provided with light breakfast. First Fridays offer a great opportunity to meet IP leadership and case managers as well as network with other inventors and entrepreneurs at UCLA. To sign up for a “first Friday” in the next few months, click here.

 

 

L.E.K. Consulting Information Session

  • August 23 05:08pm
  • Written by: Samantha Le
  • Categories:News

The UCLA ADCC (Advanced Degree Consulting Club) is pleased to announce that L.E.K. is coming to campus to hold a recruiting info session on Wednesday, September 5th at 5:00pm in BSRB 154.

L.E.K. Consulting is an international business consulting firm with a global network of twenty offices in North America, Europe, Asia, and Australia. L.E.K.’s primary goal is to help clients increase value to both customers and shareholders. L.E.K.’s business covers the full range of services offered by top consultancies: growth strategy development, marketing strategy development, value management consulting, and merger and acquisition support. L.E.K. consultants assist CEOs, Senior Management, and Boards in resolving critical issues such as new product introductions, investment allocation decisions, pricing analyses, and acquisition due diligence. L.E.K. is currently recruiting for Life Sciences Specialist positions in the U.S. To learn more about L.E.K. Consulting please visit the website at www.lek.com<http://www.lek.com/>

We invite you to participate in this information session on Wednesday, September 5th at 5:00pm. The venue will be the BSRB 154 auditorium: 615 Charles E Young Dr S, UCLA, Los Angeles, CA 90095. There will be a short presentation that will enable you to learn more about L.E.K., the Life Sciences Specialist role and the career path at this firm. Immediately following the presentation there will be time to speak with representatives from this firm, which will be a great opportunity to learn more about our Life Sciences practice.

Damon Runyon Cancer Foundation Fellowship (Aug. 15th)

  • August 07 08:08pm
  • Written by: Samantha Le
  • Categories:News

The deadline to apply for the Damon Runyon Cancer Foundation’s semiannual fellowship award is approaching on August 15th. We encourage you to review this opportunity and communicate with your faculty to submit applications to the foundation if interested.

Damon Runyon Fellowship Award—August 15, 2012 and March, 15, 2013
The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining his/her career goals. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. Damon Runyon Postdoctoral Research Fellowships are granted for a three-year term with second- and third-year funding contingent upon satisfactory progress reports. Awards are either $50,000 or $60,000 per year.                                                                               http://www.damonrunyon.org/for_scientists/more/fellowship_award_overview

Primary Criteria used to evaluate applicants are:

•        the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques and clarity of presentation)
•        the qualifications, experience and productivity of both the candidate and the Sponsor
•        the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate’s ability to conduct innovative and substantive research.  The proposed research and training environment should represent a new opportunity for the candidate to expand his/her scientific skill set.  Direct extensions of the candidate’s graduate work (in approach, technique or exact area of study) will not be funded.
All documents need to be received by the Foundation on the deadline, not simply postmarked by the due date.

If faculty need assistance with the application process they can contact Jennifer Foley (jfoley@support.ucla.ed<mailto:jfoley@support.ucla.ed>), College Director of Corporate & Foundation Relations.  Please ask faculty to let Jennifer know if they are applying, UCLA has a relationship with this foundation and can support submissions that they know have been submitted.

Please also note that Damon Runyon offers the Damon Runyon-Rachleff Innovation Award, a 3 year, $450,000 fellowship, that has a June 1, 2013 deadline.

Since 2006, two Daman Runyon Fellowships have been awarded to Life Sciences, which are the two UCLA has received  in that time. In 2010, Christopher Hale, Microbiology, Immunology, and Molecular Genetics, was named a Fellow, under the sponsorship of Steve Jacobsen, for his project, “Understanding How a Histone Methyltransferase Links DNA Replication, Repair, and Transcription.” With an extension, he is currently in what should be the final year of the grant.

Last year, Yangling Wang, studying under Jeffery Miller in the Department of Molecular, Cell, and Developmental Biology, received the postdoctoral research fellowship for the project, “Diversity Generating Retroelement-Mediated Surface-Protein Display in Bacteroides Fragilis and Its Roles in Host-Microbe Interactions.” Both Yangling and Christopher received a three year $156,000 grant.

As a potential to catapult research careers, in the third year of the fellowship, the Damon Runyon Foundation offers an opportunity to apply for a $100,000 award for one year. This award, Dale F. Frey Award for Breakthrough Scientists, enables Fellows to complete their training under

Damon Runyon-Rachleff Innovation Award—June 1, 2013
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. The award is for three years and $450,000.
Applications will be evaluated based on the following:
•       The applicant’s capacity to conduct bold, exceptionally creative research.
•       The novelty and creativity of the proposed research.  Incremental research will not be funded.
•       The potential of the proposed research to lead to advances that will significantly impact the prevention, diagnosis, treatment or basic understanding of cancer.
•       The applicant’s lack of resources to pursue the proposed research.
http://www.damonrunyon.org/for_scientists/more/innovation_award_overview

The lone UCLA awardee of the Innovation Award was Heather Christofk, Department of Moleular and Medical Pharmacology, in 2010 for her project: “Regulation of Cancer Metabolism.” Good luck to all applicants, please let us know if we can be of assistance. 

UCLA Office of Intellectual Property Summer Internship Opportunities

  • June 06 09:06pm
  • Written by: Samantha Le
  • Categories:News

In addition to educating the academic community, these programs were designed to give our graduate students/postdocs experience in the fields of technology commercialization, marketing, and intellectual property management.  Past interns have successfully transitioned into careers in research science, consulting, business development, intellectual property law, and technology transfer.

 

Please note that the deadline to submit materials for these programs is June 25th.

For more information, access the flyer below.

UCLA OIP Internship Programs